Prot# 0105: A Phase I/II Study of an Antitumor Vaccination Using alpha(1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients with Pancreatic Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date11/4/059/12/06

Funding

  • NewLink Genetics Corporation (-)